tiprankstipranks
Trending News
More News >
Anthera Pharmaceuticals, Inc. (ANTH)
:ANTH
US Market

Anthera Pharmaceuticals (ANTH) Financial Statements

Compare
235 Followers

Anthera Pharmaceuticals Financial Overview

Anthera Pharmaceuticals's market cap is currently $26.00. The company's EPS TTM is $; its P/E ratio is ―; Anthera Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Dec 21Dec 20Dec 19Dec 17
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ -281.00K
Operating Income$ 0.00$ 0.00$ 0.00$ 0.00$ -36.43M
EBITDA$ 0.00$ 0.00$ 0.00$ 0.00$ -26.59M
Net Income$ 0.00$ 0.00$ 0.00$ 0.00$ -16.93M
Balance Sheet
Cash & Short-Term Investments$ 0.00$ 0.00$ 0.00$ 0.00$ 2.20M
Total Assets$ 0.00$ 0.00$ 0.00$ 0.00$ 3.67M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ 0.00$ 0.00$ 0.00$ 0.00$ -2.20M
Total Liabilities$ 0.00$ 0.00$ 0.00$ 0.00$ 9.17M
Stockholders' Equity$ 0.00$ 0.00$ 0.00$ 0.00$ -5.50M
Cash Flow
Free Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ -36.90M
Operating Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ -36.90M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 18.25M
Currency in USD

Anthera Pharmaceuticals Earnings and Revenue History

Anthera Pharmaceuticals Debt to Assets

Anthera Pharmaceuticals Cash Flow

Anthera Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis